Design of 9-β-D-Arabinofuranosyladenine (Ara-A) Transdermal Delivery System for Animal Studies: Regulation of Drug Concentration In Vivo
- 1 October 1991
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 80 (10), 935-941
- https://doi.org/10.1002/jps.2600801007
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Preformulation of an Ara-A transdermal delivery system: Membrane fabrication and characterizationJournal of Controlled Release, 1987
- Influence of 1-Dodecylazacycloheptan-2-one (Azone) on the Topical Therapy of Cutaneous Herpes Simplex Virus Type 1 Infection in Hairless Mice with 2′,3′-Di-o-acetyl-9-β-D-Arabinofuranosyladenine and 5′-O-Vaieryl-9-β-D-ArabinofuranosyladenineJournal of Pharmaceutical Sciences, 1985
- Calculation of Cutaneous Metabolic Rate Constant from Diffusion ModelJournal of Pharmaceutical Sciences, 1980
- Physical Model Evaluation of Topical Prodrug Delivery—simultaneous Transport and Biocnversion of Vidarabine-5′-valerate II: Parameter DeterminationsJournal of Pharmaceutical Sciences, 1979